Orthopedic device manufacturer Biomet has reported adjusted operating income of $229.2 million for the fourth quarter of fiscal year 2012, indicating a 6 percent increase from the same period last year. The device giant also reported net sales totaling $739.5 million for the fourth quarter of fiscal year 2012, a 3 percent increase compared to the same quarter last year, as well as an operating loss of $378 million during the fourth quarter of fiscal year 2012, compared to an operating loss of $847.3 million for the same period last year.
More Articles on Biomet:
41 Orthopedic & Spine Devices Receive FDA 510(k) Clearance in June
20 Spine Devices Receive FDA 510(k) Clearance in June
Biomet Closes DePuy Trauma Acquisition